Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,599,800
+$8,868,200 QoQ
Shares Held
590,000
+63.9% QoQ
Ownership
0.385%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Dec 31, 2023CallValue
$85,400
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $316,393,134 across 63 Biotechnology names. TGTX ranks #6 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | ANAB |
Anaptysbio, Inc
|
625,000 | $34,662,500 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
This page
|
590,000 | $19,599,800 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
775,000 | $11,206,500 |
All Filings in TGTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,599,800 | 590,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,731,600 | 360,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,740,625 | 325,000 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $11,631,850 | 295,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $20,979,700 | 697,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,547,650 | 1,135,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,906,000 | 1,400,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $24,716,250 | 1,625,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $28,609,000 | 1,675,000 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $85,400 | 5,000 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $11,286,000 | 1,350,000 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $11,656,000 | 775,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,787,500 | 1,250,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,481,280 | 2,784,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,025,000 | 3,300,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,715,491 | 2,598,895 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $22,933,000 | 1,207,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,564,858 | 828,271 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,436,482 | 243,271 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,725,662 | 243,271 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $20,718,057 | 398,271 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,657,731 | 398,271 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,758,319 | 398,271 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,918,986 | 398,271 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||